This Article Full Text Full Text (PDF) All Versions of this Article: 35/7/1738    most recent 01.STR.0000131480.03994.b1v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hirt, L. Articles by Bogousslavsky, J. Search for Related Content PubMed PubMed Citation Articles by Hirt, L. Articles by Bogousslavsky, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB GLUCOSE OXYGEN Related Collections Animal models of human disease Ischemic biology - basic studies Neuroprotectors

(Stroke. 2004;35:1738.)
© 2004 American Heart Association, Inc.

Original Contributions

D-JNKI1, a Cell-Penetrating c-Jun-N-Terminal Kinase Inhibitor, Protects Against Cell Death in Severe Cerebral Ischemia

Lorenz Hirt, MD; Jérôme Badaut, PhD; Jonathan Thevenet; Cristina Granziera, MD; Luca Regli, MD; Fabienne Maurer, PhD; Christophe Bonny, PhD Julien Bogousslavsky, MD

From the Neurology Service (L.H., J.T., C.G., J.B.), the Neurosurgery Service (J.B., L.R.), and the Division of Medical Genetics (F.M., C.B.), CHUV, Lausanne, Switzerland.

Correspondence to Dr Lorenz Hirt, Service de Neurologie, Centre Hospitalier Universitaire Vaudois, BH19-208, 1011 Lausanne, Switzerland. E-mail Lorenz.Hirt{at}chuv.hospvd.ch

Background and Purpose— In 2 models of severe ischemic injury, we have evaluated the neuroprotective action of D-JNKI1, a cell-penetrating and protease-resistant peptide selectively inhibiting the c-Jun-N-terminal kinase (JNK).

Methods— Hippocampal slices from newborn rats were subjected to oxygen (5%) and glucose (1 mmol/L) deprivation for 30 minutes. Cell death was evaluated with propidium iodide, and the evoked potential responses were recorded in the CA1 region after stimulation in CA3. Male ICR-CD1 mice were subjected to permanent endoluminal "suture" middle cerebral artery occlusion (MCAo). The lesion size was determined after 24 hours by triphenyl-tetrazolium chloride staining, and neurological scores and rotarod treadmill performance were used to evaluate the neurological outcome.

Results— In vitro, D-JNKI administration 6 hours after oxygen glucose deprivation reduced cell death at 24 hours from 21%±8% (n=10) to 5%±3% (n=7, P<0.01). This protective effect was still seen at 48 hours, paralleled by an improved amplitude of the evoked potential response. In vivo in the mouse, D-JNKI1 administration 3 hours after ischemia significantly reduced the infarct volume from 162±27 mm³ (n=14) to 85±27 mm³ (n=9, P<0.001). The functional outcome was also improved.

Conclusions— JNK inhibition prevents cell death induced by oxygen and glucose deprivation in hippocampal slice cultures in vitro and by permanent suture MCAo in vivo. D-JNKI1 is a powerful neuroprotectant in models of both mild and severe cerebral ischemia, with an extended therapeutic window. Further investigations are needed to identify the relevant JNK target(s) mediating ischemic neuronal death.

Key Words: MAP kinase signaling system • gene products, tat • peptides • cerebral ischemia, focal • tissue culture

This article has been cited by other articles:

				A. Melani, S. Cipriani, M. G. Vannucchi, D. Nosi, C. Donati, P. Bruni, M. G. Giovannini, and F. Pedata Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia Brain, June 1, 2009; 132(6): 1480 - 1495. [Abstract] [Full Text] [PDF]

				M. Melino, C. S. Hii, S. R. McColl, and A. Ferrante The Effect of the JNK Inhibitor, JIP Peptide, on Human T Lymphocyte Proliferation and Cytokine Production J. Immunol., November 15, 2008; 181(10): 7300 - 7306. [Abstract] [Full Text] [PDF]

				Y. Xu, S. Huang, Z.-G. Liu, and J. Han Poly(ADP-ribose) Polymerase-1 Signaling to Mitochondria in Necrotic Cell Death Requires RIP1/TRAF2-mediated JNK1 Activation J. Biol. Chem., March 31, 2006; 281(13): 8788 - 8795. [Abstract] [Full Text] [PDF]